IPO
Genomics-focused diagnostics co. Neuberg plans Rs.4,000-Cr IPO in FY28
Chennai-based diagnostics firm Neuberg Diagnostics is preparing for an initial public offering (IPO) in FY28, with plans to raise between Rs.3,500-Cr and Rs.4,000-Cr. The proposed IPO is expected to include both a fresh issue and a secondary share sale for existing private equity investors.The company, founded by GSK Velu, offers genomics testing and longevity programs. In addition to its IPO plans, the company aims to raise Rs.500-Cr in a pre-IPO funding round over the next three to six months.Neuberg intends to use these funds to finance four to five acquisitions, with a focus on Mumbai, Maharashtra, Delhi, and the NCR region. To support its growth initiatives, the company expects to invest between Rs.700-Cr and Rs.1,000-Cr, utilising a combination of fresh capital, internal accruals, and debt. Neuberg reported gross revenue of Rs.1,400-Cr in FY26.
In Jan 2025, Neuberg Diagnostics had attracted about $ 109 M from Kotak Alternate.For FY25, Neuberg Diagnostics had reported about INR 464 Cr in Operating Income and about INR 16 Cr in PAT.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
